secwatch.observer — SEC 8-K summary
======================================

Issuer:     Opus Genetics, Inc. (IRD)
CIK:        0001228627
Form:       8-K
Filed at:   2023-12-06T23:59:59+00:00
Accession:  0001140361-23-056425
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ocuphire promotes Ronil Patel to Chief Business Officer; grants 74K options and 50K RSUs
--------------------------------------------------------------------------------

- Ronil Patel, age 40, promoted to Chief Business Officer effective December 1, 2023; previously SVP of Operations and Business Development.
- Base salary set at $350,000, increasing to $400,000 upon meeting certain milestones (e.g., $100M cash balance or strategic term sheet).
- Eligible for annual bonus targeted at 45% of base salary (up from 40%).
- Granted incentive stock option to purchase 74,538 shares and RSU for 49,692 shares, vesting over ~2.5 years.
- Background: 15 years experience; involved in deals over $300M; previously at Point Guard Partners.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1228627/000114036123056425/0001140361-23-056425-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1228627/000114036123056425/ef20015996_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-056425

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer